Benoit Gravel - Net Worth and Insider Trading

Benoit Gravel Net Worth

The estimated net worth of Benoit Gravel is at least $91,864 dollars as of 2024-05-25. Benoit Gravel is the Director of Medexus Pharmaceuticals Inc and owns about 56,358 shares of Medexus Pharmaceuticals Inc (TSX:MDP) stock worth over $91,864. Details can be seen in Benoit Gravel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Benoit Gravel has not made any transactions after 2024-02-13 and currently still holds the listed stock(s).

Transaction Summary of Benoit Gravel

To

Benoit Gravel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Benoit Gravel owns 1 companies in total, including Medexus Pharmaceuticals Inc (TSX:MDP) .

Click here to see the complete history of Benoit Gravel’s form 4 insider trades.

Insider Ownership Summary of Benoit Gravel

Ticker Comapny Transaction Date Type of Owner
TSX:MDP Medexus Pharmaceuticals Inc 2024-02-13 Director

Benoit Gravel Latest Holdings Summary

Benoit Gravel currently owns a total of 1 stock. Benoit Gravel owns 56,358 shares of Medexus Pharmaceuticals Inc (TSX:MDP) as of February 13, 2024, with a value of $91,864.

Latest Holdings of Benoit Gravel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
TSX:MDP Medexus Pharmaceuticals Inc 2024-02-13 56,358 1.63 91,864

Holding Weightings of Benoit Gravel


Benoit Gravel Form 4 Trading Tracker

According to the SEC Form 4 filings, Benoit Gravel has made a total of 1 transactions in Medexus Pharmaceuticals Inc (TSX:MDP) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Medexus Pharmaceuticals Inc is the acquisition of 3,200 shares on February 13, 2024, which cost Benoit Gravel around $5,408.

Insider Trading History of Benoit Gravel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Benoit Gravel Trading Performance

GuruFocus tracks the stock performance after each of Benoit Gravel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Benoit Gravel is -0.6%. GuruFocus also compares Benoit Gravel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Benoit Gravel within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Benoit Gravel's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Benoit Gravel

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.19
Relative Return to S&P 500(%) -8.47

Benoit Gravel Ownership Network

Ownership Network List of Benoit Gravel

No Data

Ownership Network Relation of Benoit Gravel


Benoit Gravel Owned Company Details

What does Medexus Pharmaceuticals Inc do?

Who are the key executives at Medexus Pharmaceuticals Inc?

Benoit Gravel is the Director of Medexus Pharmaceuticals Inc. Other key executives at Medexus Pharmaceuticals Inc include Senior Officer Benoît Hébert , and Director & Senior Officer Kenneth d'Entremont .

Medexus Pharmaceuticals Inc (TSX:MDP) Insider Trades Summary

Over the past 18 months, Benoit Gravel made 1 insider transaction in Medexus Pharmaceuticals Inc (TSX:MDP) with a net purchase of 3,200.

In summary, during the past 3 months, insiders sold 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Medexus Pharmaceuticals Inc (TSX:MDP) were sold and 3,200 shares were bought by its insiders, resulting in a net purchase of 3,200 shares.

Medexus Pharmaceuticals Inc (TSX:MDP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Medexus Pharmaceuticals Inc Insider Transactions

No Available Data

Benoit Gravel Mailing Address

Above is the net worth, insider trading, and ownership report for Benoit Gravel. Currently GuruFocus does not have mailing address information for Benoit Gravel.

Discussions on Benoit Gravel

No discussions yet.